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Abstract
The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related
ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal
diseases. Work in both (drugs and vaccines) areas is closely related - from preclinical research and development to
manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and
monitoring. Over the last decade, tremendous efforts have been made in the biomedical ontology community to
ontologically represent various areas associated with vaccines and drugs – extending existing clinical terminology
systems such as SNOMED, RxNorm, NDF-RT, and MedDRA, developing new models such as the Vaccine Ontology (VO)
and Ontology of Adverse Events (OAE), vernacular medical terminologies such as the Consumer Health Vocabulary
(CHV). The VDOS workshop series provides a platform for discussing innovative solutions as well as the challenges in
the development and applications of biomedical ontologies for representing and analyzing drugs and vaccines, their
administration, host immune responses, adverse events, and other related topics. The five full-length papers included in
this 2014 thematic issue focus on two main themes: (i) General vaccine/drug-related ontology development and
exploration, and (ii) Interaction and network-related ontology studies.
Introduction and background
Drugs and vaccines have been critical to prevent and
treat human and animal diseases. Work in both (drugs
and vaccines) areas is closely related - from preclinical
research and development to manufacturing, clinical trials,
government approval and regulation, and post-licensure
usage surveillance and monitoring. Ontologies can serve
important roles in managing, normalizing, sharing, and
leveraging drug and vaccine relevant data. The 2014
“Vaccine and Drug Ontology Studies” workshop (VDOS
2014) was an international forum for researchers to
identify, propose, and discuss solutions for important
research problems in ontology representation and analysis
of vaccine and drug development, administration, func-
tion mechanisms, safety, and education.
VDOS 2014 was held on October 7, 2014, in Houston,
Texas. This workshop was part of the Fifth International
Conference on Biomedical Ontology (ICBO 2014). The
workshop attracted interests from many international
attendees, including paper presenters, academic and
government scientists, postdoctoral fellows, and graduate
students. After a rigorous peer review process (all submis-
sions have been reviewed by at least three independent
reviewers), five full-length papers were accepted for pro-
ceeding paper publications and oral presentations in the
workshop. After additional reviewing by the independent
reviewers, workshop co-organizers, and the journal
editors, the selected five full-length papers were extended
and accepted for publication in the thematic track of the
Journal of Biomedical Semantics (JBMS).
The VDOS-2014 workshop is the 3rd in this series.
The first workshop of the series was organized as the
“Vaccine and Drug Ontology in the Study of Mechanism
and Effect” workshop (VDOSME 2012) [1] on July 21,
2012, in Graz, Austria, as part of the third International
Conference on Biomedical Ontology (ICBO 2012). In 2013,
the name has been changed to “Vaccine and Drug Ontology
Studies (VDOS)” to reflect the expansion in the scope to
more than just mechanism and effect. The workshop
series also covers vaccine and drug-related clinical data
representation and analysis, including clinically reported
vaccine and drug adverse events. VDOS 2013 was held
on July 7, 2013, in Montreal, Qc, Canada [2].
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Summary of selected papers in the thematic issue
The five papers selected for this thematic issue are ex-
tended versions of the original full-length papers presented
at the VDOS 2014. This year the workshop focuses on two
main themes: (i) General vaccine/drug-related ontology
development and exploration, and (ii) Interaction and
network-related ontology studies.
In the area of general vaccine/drug-related ontology de-
velopment and exploration, Winnenburg and Bodenreider
introduced their approach on identifying common class-
level signals for every individual drug in a class [3]. They
created a dataset of Adverse Drug Events (ADE) based on
information extracted from PubMed abstracts and aggre-
gated drugs into Anatomical Therapeutic Chemical (ATC)
classes and ADEs into Medical Subject Headings (MeSH)
terms. They then applied a visual approach to uncover
known associations and a computational approach to
systematically analyze the associations between drug classes
and ADEs. Amith and Tao introduced their Vaccine
Information Statement Ontology (VISO), which is a
comprehensive vaccine information ontology that can
support personal health information applications using
patient-consumer lexicon, and lead to outcomes that
can improve patient education [4]. The current VISO con-
tains the knowledge included in the Vaccine Information
Statement (VIS) documents collected from the USA
Centers for Disease Control and Prevention (CDC)
website. The overarching goal of the VISO is to positively
influence the development of intelligent ontology-driven
applications and mitigate the knowledge gap that often
exists in patients seeking accurate and reliable information
but encountering complex or inaccurate sources.
In the area of interaction and network-related
ontology studies, Peters et al. investigated the drug –
drug interaction (DDI) information in two publically
available drug resources, NDF-RT and DrugBank [5].
Their study indicated that the overlaps of DDIs be-
tween the two resources are limited. Further studies
need to be conducted to either determine how to best
leverage the DDI information included in these two
resources in clinical and translational applications.
Hur et al. introduced their work on the development
of the interaction Network Ontology (INO) with an
aim to classify over 800 interaction keywords for literature
mining various interactions between genes and proteins
[6]. Based on the INO-classified interaction type hierarchy
and the Vaccine Ontology (VO)-based vaccine hierarchy, a
modified Fisher’s exact test on PubMed literature mined
results was established to successfully analyze signifi-
cantly over- and under-represented enriched gene-gene
interaction types within the vaccine domain. This study
demonstrated that hierarchical ontological definitions
facilitate novel approaches for literature mining and
analysis of gene interaction networks. Zhang et al.
introduce a novel approach that combines ontologies
and network analysis technologies for studying sex-
associated patterns in vaccine adverse events [7]. The
authors leverage data downloaded from the Vaccine
Adverse Event Report System (VAERS) and con-
structed a condition-specific association network. The
outcome of this research can potentially provide guidance
on sex-specific dose recommendations in personalized
vaccinology.
Workshop presentations and discussions
In the 2014 VDOS workshop, the five full-length papers
described above were orally presented. In addition, the
program also included a keynote speech and a podium
abstract presentation. The keynote speech was given by
Dr. Khalid F. Almoosa, Associate Professor of Medicine at
the Department of Internal Medicine, UTHealth Medical
School, Houston, TX. Dr. Almoosa also serves as the
Vice-Chair for Healthcare Quality and the Director of
Interprofessional Collaboration at UTHealth. In his
keynote, Dr. Almoosa discussed important issues in
healthcare quality and safety and the roles of vaccine and
drug safety in healthcare quality management. For the
podium abstract presentation, Dr. Yongqun He provided
updates on the development of the Ontology of Adverse
Events (OAE) and its applications. An in-depth discussion
of the OAE is available in the recently published article in
Journal of Biomedical Semantics [8].
The discussion session of the workshop focused on
the topic of “Drug and vaccine ontology informatics”, we
first discussed the similarities and differences between
the adverse event ontologies in the Open Biological and
Biomedical Ontologies (OBO) domain (e.g., OAE and
AERO) and non-OBO style ontologies (e.g., MedDRA
and SNOMED). The necessity and possible approaches
on how to bridge OBO and non-OBO ontologies were
explored. Furthermore, the participants of the
workshop discussed ontology-based clinical and ex-
perimental data processing and analysis, including
ontology-supported literature mining of biomedical and
electronic health records. We all agreed to continue the
workshop in 2015 which would be held in conjunction
with the ICBO-2015 conference at Lisbon, Portugal, in the
end of July 2015.
Overall, the VDOS 2014 workshop was well received
with positive feedbacks. The VDOS workshop series
have served and will continue to serve a platform for
biomedical and clinical researchers to discuss ontology-
relevant issues and progress in drug and vaccine
research and applications.
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